HK2 and diffuse large B-cell lymphoma: Moreover, we discovered that over-expression of HKII was associated with a shorter PFS in DLBCL treated with R+CHOP and an inferior OS in DLBCL patients treated with CHOP- or R-CHOP-like therapy.